Clinical Trials Logo

Heavy Smoking clinical trials

View clinical trials related to Heavy Smoking.

Filter by:
  • None
  • Page 1

NCT ID: NCT04413669 Recruiting - Heavy Smoking Clinical Trials

Bronchoscopy Screening for High-risk Population of Lung Cancer With Severe Smoking With Negative LDCT Screen

Start date: December 26, 2019
Phase: N/A
Study type: Interventional

Based on the previous work of LDCT screening, in order to improve the screening rate of central lung cancer for LDCT negative and severe smokers, the investigators plan to conduct China's first large-scale fluorescent bronchoscopy screening test.

NCT ID: NCT03727958 Not yet recruiting - HEAVY SMOKING Clinical Trials

Simultaneous Coronary Artery Evaluation and Lung Cancer CT Screening

SIMULTANEOUS
Start date: November 1, 2018
Phase: N/A
Study type: Interventional

Cardiac computed tomography (CT) is often performed in patients who are at high risk for lung cancer in whom screening is currently recommended. This pilot randomized study will test the feasibility, safety and diagnostic ability of a novel ultra-low-dose CT protocol that allows concomitant coronary artery evaluation and lung screening. Current or former heavy smoker subjects with suspected or known coronary artery disease will be randomized to undergo CT assessment of either thoracic area only or both coronary arteries and thoracic area. Primary end-points will be the effective contrast and radiation doses.

NCT ID: NCT00302432 Completed - Schizophrenia Clinical Trials

The Effect of Cigarette Holders, Plastic Menthol Cigarettes, and Cognitive Behavioral Therapy for Smoking Reduction Among Schizophrenia Inpatients: A Comparative Study

Start date: March 2006
Phase: N/A
Study type: Interventional

This study aims: 1. to assess the effect of smoking reduction programs (behavior therapy alone or behavior therapy with cigarette holders; "Flowers Menthol" plastic cigarettes with menthol) on cigarette smoking habits in an antipsychotic treated schizophrenia population.

NCT ID: NCT00284219 Completed - Heavy Smoking Clinical Trials

High-Frequency Repetitive Transcranial Magnetic Stimulation Assists In Smoking Cessation

Start date: July 2005
Phase: N/A
Study type: Interventional

Cigarette smoking is a major public health problem causing significant morbidity and mortality. Yet, smoking cessation therapies are often ineffective at helping smokers break their addiction. The mesolimbic dopaminergic reward system plays a crucial role in mediating the reinforcing effects of nicotine. Recently, acute high frequency repetitive transcranial magnetic stimulation (rTMS) of frontal brain regions has been shown to efficiently modulate the mesolimbic dopamine systems in both animals and humans. For this reason, we investigated whether 10 high-frequency (10Hz) rTMS treatments over the left dorsolateral prefrontal cortex can help people to withdraw smoking in comparison to placebo rTMS. Smokers seeking to quit are recruited through newspaper advertisements. Participants were randomized to 10 days of either real or placebo high frequency rTMS.